Your GRACE score provides an estimate of in-hospital and 6-month mortality risk for acute coronary syndrome. A score of 108 or below indicates low risk with less than 1% in-hospital mortality. A score between 109 and 140 represents intermediate risk with 1-3% in-hospital mortality. A score above 140 indicates high risk with greater than 3% in-hospital mortality. The 6-month post-discharge mortality follows a similar gradient, with scores above 140 predicting over 8% mortality.

The GRACE score is the most extensively validated ACS risk tool available. Unlike simpler scoring systems, it incorporates continuous variables (age, heart rate, systolic blood pressure, creatinine) which provide finer risk discrimination. The inclusion of creatinine captures renal function, an important and often underappreciated prognostic factor in ACS. Killip class and cardiac arrest at admission capture hemodynamic severity, which is the strongest short-term mortality predictor.

Use the GRACE score for all patients presenting with confirmed or suspected acute coronary syndrome, including both STEMI and NSTEMI/unstable angina. The European Society of Cardiology (ESC) guidelines specifically recommend the GRACE score as the preferred risk stratification tool in ACS. It should be calculated as early as possible after presentation, once the required clinical data (vitals, creatinine, ECG, troponin) are available.

The score guides multiple clinical decisions: the urgency of invasive management (immediate vs. within 24 hours vs. within 72 hours), the intensity of antithrombotic therapy, the level of monitoring required (ICU vs. telemetry), and discharge planning. It is also valuable for prognostic communication with patients and families and for identifying candidates who may benefit from early transfer to a PCI-capable center.

The GRACE score requires laboratory values (creatinine, troponin) that may not be immediately available at the time of initial clinical assessment. In time-critical situations such as STEMI, treatment decisions should not be delayed while awaiting the score. The original GRACE model was developed from registry data collected between 1999 and 2007, and absolute mortality rates have decreased with contemporary treatments, though relative risk stratification remains valid.

The score does not account for coronary anatomy (number of diseased vessels, left main disease), left ventricular function, or the presence of mechanical complications. It also does not incorporate newer biomarkers such as high-sensitivity troponin kinetics or BNP/NT-proBNP. The GRACE 2.0 model allows substitution of estimated Killip class when precise assessment is difficult, but the original version requires direct clinical assessment. Online calculators and apps are recommended over manual calculation due to the complexity of the weighted scoring system.